Information  X 
Enter a valid email address

Avacta Group PLC Ord 10P (AVCT)

Date Time Source Announcement
24 Feb 2021 7:00 am
RNS
Business Update
22 Feb 2021 7:00 am
RNS
Re: Press Speculation
18 Feb 2021 7:00 am
RNS
Phase I CTA for AVA6000 Approved by MHRA
16 Feb 2021 9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Results of Initial Evaluation of SARS-CoV-2 LFT
08 Feb 2021 7:00 am
RNS
Commercial Partnership with Mologic
02 Feb 2021 8:30 am
RNS
Issue of Equity
01 Feb 2021 7:00 am
RNS
AffyXell $7.3 Million Series A Financing
29 Jan 2021 11:00 am
RNS
Issue of Equity
28 Jan 2021 7:00 am
RNS
Collaboration Agreement with Bruker
07 Jan 2021 7:00 am
RNS
License Agreement with POINT Biopharma Inc.
05 Jan 2021 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
23 Dec 2020 7:00 am
RNS
Submission of CTA for AVA6000 Pro-doxorubixin
21 Dec 2020 7:00 am
RNS
License Agreement with Astrea Bioseparations
23 Nov 2020 9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
SARS-CoV-2 Rapid Antigen Test Update
18 Nov 2020 4:40 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
13 Nov 2020 2:15 pm
RNS
Issue of Equity
10 Nov 2020 11:06 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
09 Nov 2020 2:06 pm
RNS
Second Price Monitoring Extn
  2:01 pm
RNS
Price Monitoring Extension
22 Oct 2020 1:50 pm
RNS
Director/PDMR Shareholding
08 Oct 2020 9:00 am
RNS
Issue of Equity
30 Sep 2020 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  10:35 am
RNS
Launch of SARS-CoV-2 BAMS Research Test
29 Sep 2020 7:00 am
RNS
Appointment of Joint Broker
28 Sep 2020 9:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Interim Results for the Period Ended 30 June 2020
24 Sep 2020 7:00 am
RNS
Update on Integumen Collaboration
14 Sep 2020 7:00 am
RNS
Notice of Results and Investor Presentation
07 Sep 2020 7:00 am
RNS
Avacta to Launch SARS-CoV-2 ELISA Laboratory Test
02 Sep 2020 7:00 am
RNS
Expansion of COVID-19 Test Manufacturing Capacity
20 Aug 2020 4:45 pm
RNS
Issue of Equity
19 Aug 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
18 Aug 2020 3:30 pm
RNS
Issue of Equity
  7:00 am
RNS
Expanded Partnership with LG Chem Life Sciences
17 Aug 2020 7:00 am
RNS
Clarification Regarding Medusa 19 Antibody Test
11 Aug 2020 9:30 am
RNS
Holding(s) in Company
  7:00 am
RNS
Therapeutics Chief Development Officer Appointment
07 Aug 2020 7:00 am
RNS
SARS-CoV-2 Antigen Test Clinical Collaboration
06 Aug 2020 7:00 am
RNS
COVID-19 Rapid Antigen Test Manufacturing Partner
29 Jul 2020 7:00 am
RNS
Expanded Partnership with Daewoong Pharmaceutical
22 Jul 2020 7:00 am
RNS
Update on Adeptrix COVID-19 Diagnostic Test
17 Jul 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
13 Jul 2020 7:00 am
RNS
Collaboration with Integumen plc
07 Jul 2020 2:06 pm
RNS
Issue of Equity
03 Jul 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
24 Jun 2020 11:15 am
RNS
Result of General Meeting
  7:00 am
RNS
Update on COVID-19 Test Development Partnership
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t